Data / Form D filings / PURPLE BIOTECH LTD.
PURPLE BIOTECH LTD.: Form D filings
PURPLE BIOTECH LTD., a biotechnology company in Rehovot, Israel, filed 13 Form D notices with the SEC between 2016 and 2024. The latest, on July 15, 2024, reports $4.5 million sold of a $4.5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4 OPPENHEIMER STREET, SCIENCE PARK, Rehovot, Israel, 76701
- Phone
- +972-3-933-3121
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1614744
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2024 | New notice | $4,506,807 | $4,506,807 | 2 | Jul 1, 2024 | sec.gov | |
| Oct 31, 2023 | New notice | $5,434,784 | $5,434,784 | 1 | Oct 17, 2023 | sec.gov | |
| Jul 14, 2020 | New notice | Indefinite | $0 | 1 | May 24, 2020 | sec.gov | |
| May 15, 2020 | New notice | $10,000,001 | $10,000,001 | 3 | May 6, 2020 | sec.gov | |
| May 4, 2020 | New notice | $6,500,000 | $6,500,000 | 3 | Apr 19, 2020 | sec.gov | |
| Jan 21, 2020 | New notice | Indefinite | $0 | 2 | Jan 7, 2020 | sec.gov | |
| Jan 24, 2019 | New notice | $6,000,001 | $6,000,001 | 2 | Jan 18, 2019 | sec.gov | |
| Jun 7, 2018 | New notice | $8,150,000 | $8,150,000 | 4 | Jun 5, 2018 | sec.gov | |
| Mar 26, 2018 | New notice | Indefinite | $0 | 2 | Mar 15, 2018 | sec.gov | |
| Nov 1, 2017 | New notice | Indefinite | $0 | 1 | Oct 30, 2017 | sec.gov | |
| Aug 8, 2017 | New notice | $1,981,005 | $1,981,005 | 14 | Jul 11, 2017 | sec.gov | |
| May 2, 2016 | New notice | Indefinite | $0 | 1 | May 2, 2016 | sec.gov | |
| Feb 4, 2016 | New notice | Indefinite | $0 | 1 | Jan 20, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric Rowinsky | Director | |
| Lior Fhima | Executive Officer | |
| Ido Morpurgo | Executive Officer | |
| Michael Schickler | Executive Officer | |
| Simcha Rock | Director | |
| Suzana Nahum-Zilberberg | Director | |
| Yael Margolin | Director | |
| Isaac Israel | Director | |
| Hadas Reuveni | Executive Officer | |
| Gil Efron | Executive Officer | |
| Ori Hershkovitz | Director | |
| Ido Agmon | Director | |
| Robert Gagnon | Director |
Every Form D from the week of Jul 15, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PURPLE BIOTECH LTD. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.